New Analyst Ratings On American Vanguard Corporation (NYSE:AVD)
Recently stock market analysts have updated their consensus ratings on shares of American Vanguard Corporation (NYSE:AVD). The latest broker reports which are currently outstanding on Monday 9th of May state 0 analysts have a rating of “strong buy”, 0 analysts “buy”, 0 analysts “neutral”, 0 analysts “sell” and 0 analysts “strong sell”.
Most recent broker ratings
05/04/2016 – American Vanguard Corporation was downgraded to “neutral” by analysts at Roth Capital. They now have a USD 14.5 price target on the stock.
01/04/2016 – American Vanguard Corporation was downgraded to “underweight” by analysts at Piper Jaffray. They now have a USD 11 price target on the stock.
05/13/2015 – American Vanguard Corporation was upgraded to “hold” by analysts at Zacks.
05/06/2015 – BB&T Capital Markets began new coverage on American Vanguard Corporation giving the company a “buy” rating. They now have a USD 15 price target on the stock.
03/15/2015 – American Vanguard Corporation had its “buy” rating reiterated by analysts at Topeka Capital Markets. They now have a USD 14 price target on the stock.
05/14/2014 – American Vanguard Corporation had its “neutral” rating reiterated by analysts at SunTrust. They now have a USD 16 price target on the stock.
03/03/2014 – American Vanguard Corporation was downgraded to “hold” by analysts at TheStreet.
12/23/2013 – American Vanguard Corporation had its “strong-buy” rating reiterated by analysts at Feltl & Co.. They now have a USD 30.7 price target on the stock.
American Vanguard Corporation has a 50 day moving average of 15.69 and a 200 day moving average of 14.02. The stock’s market capitalization is 386.37M, it has a 52-week low of 9.63 and a 52-week high of 17.41.
The share price of the company (NYSE:AVD) was up +2.95% during the last trading session, with a high of 13.45 and the volume of American Vanguard Corporation shares traded was 277817.
View other investors thoughts on American Vanguard Corporation on our new Stock Talk discussion platform. Sign up for free to contribute to the community and view research provided from other investors for any stock listed on the LSE, NYSE or NASDAQ.